1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAUY922A2101, NCT00526045
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAUY922A2202, Eudra CT 2009-015407-47, NCT01084330
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAUY922A2109, 2009-015628-27, NCT01271920
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CAUY922A1101, NCT01132625
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SCRI GI 143, NCT01226732
|
|
6.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 27112008 version 1, 2008-005751-26, NCT01081600
|